Acetylation: a novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans

Surgery. 2008 Aug;144(2):204-16. doi: 10.1016/j.surg.2008.03.034.

Abstract

Background: Hemorrhage induces an imbalance in histone acetyl transferase/histone deacetylase (HAT/HDAC) ratio. Correction of this imbalance with histone deacetylase inhibitors (HDACI) improves survival. We aimed to identify whether this was due to modulation of the post-shock immune response.

Methods: We established a "two-hit" model in which rats (n=11; 5-6/group) and humans (n=10; 5/group) sustained trauma/hemorrhage, followed by exposure of splenic leukocytes to lipopolysaccharide (LPS, 10 ng/mL) for 8 or 24 hours. The leukocytes were treated with: No treatment, SAHA (suberoylanilide hydroxamic acid, HDACI, 400 nM), or Garcinol (HAT inhibitor, 20 microM).

Results: Hemorrhage in the animals produced severe shock and a pro-inflammatory state. SAHA reduced TNFa secretion in the hemorrhaged leukocytes after LPS "second-hit" (34.0%, P = .003), whereas it increased transcript levels of TNFa and IL-1b (2.1+/-0.3 and 5.1+/- 2.2 fold respectively, P < .05). Leukocytes from trauma patients displayed 2 distinct responses to SAHA after LPS "second-hit," with markedly increased or decreased cytokine levels.

Conclusions: SAHA normalizes TNFa levels following hemorrhage and LPS "second hit" in the rats, whereas trauma patients respond to SAHA in 2 distinct patterns, with either marked attenuation or exaggeration of inflammatory cytokines. Cytokine levels were independent of gene expression, implicating acetylation of non-nuclear proteins as the dominant regulatory mechanism.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Abdominal Injuries / metabolism*
  • Acetylation
  • Adult
  • Animals
  • Cell Culture Techniques
  • Female
  • Hemorrhage / metabolism
  • Hemorrhage / physiopathology
  • Histone Acetyltransferases / metabolism*
  • Histone Deacetylase Inhibitors
  • Histone Deacetylases / metabolism*
  • Humans
  • Hydroxamic Acids / pharmacology
  • Inflammation
  • Interleukin-1beta / blood
  • Interleukin-1beta / genetics
  • Leukocytes / metabolism
  • Lipopolysaccharides / pharmacology
  • Male
  • Rats
  • Rats, Inbred WKY
  • Shock, Hemorrhagic / complications
  • Shock, Hemorrhagic / immunology
  • Shock, Hemorrhagic / metabolism*
  • Shock, Hemorrhagic / therapy
  • Spleen / metabolism
  • Splenectomy
  • Systemic Inflammatory Response Syndrome / etiology
  • Systemic Inflammatory Response Syndrome / metabolism
  • Transcriptional Activation
  • Tumor Necrosis Factor-alpha / blood
  • Tumor Necrosis Factor-alpha / genetics
  • Vorinostat

Substances

  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Interleukin-1beta
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Vorinostat
  • Histone Acetyltransferases
  • Histone Deacetylases